SW · SOON.SW
Sonova Holding AG
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Stäfa 8712
- Website
- sonova.com
Price · as of 2025-03-31
$171.20
Market cap 12.04B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $239.32 | +39.79% |
| Intrinsic Value(DCF) | $106.78 | -37.63% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $130.99 | -23.49% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $66.37 | $78.15 | $9.64 | $19.60 | $54.16 |
| 2012 | $74.18 | $85.42 | $5.24 | $9.17 | $30.68 |
| 2013 | $86.76 | $89.89 | $2.35 | $0.14 | $30.51 |
| 2014 | $116.61 | $120.02 | $9.08 | $13.64 | $82.93 |
| 2015 | $115.24 | $129.57 | $7.62 | $11.28 | $65.04 |
| 2016 | $102.58 | $128.43 | $5.90 | $6.93 | $50.27 |
| 2017 | $145.95 | $159.83 | $10.29 | $0.00 | $123.10 |
| 2018 | $157.85 | $164.50 | $13.13 | $3.84 | $110.47 |
| 2019 | $209.44 | $182.82 | $38.67 | $1.75 | $85.76 |
| 2020 | $182.45 | $170.86 | $8.57 | $0.00 | $101.93 |
| 2021 | $308.62 | $256.11 | $35.13 | $58.00 | $0.00 |
| 2022 | $263.31 | $247.89 | $85.79 | $5.35 | $375.84 |
| 2023 | $228.10 | $245.09 | $111.65 | $0.00 | $202.59 |
| 2024 | $268.07 | $246.71 | $7.07 | $0.00 | $53.02 |
| 2025 | $246.81 | $239.32 | $11.43 | $0.00 | $130.99 |
AI valuation
Our deep-learning model estimates Sonova Holding AG's (SOON.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $239.32
- Current price
- $171.20
- AI upside
- +39.79%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$106.78
-37.63% upside
Graham-Dodd
—
— upside
Graham Formula
$130.99
-23.49% upside
About Sonova Holding AG
Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
- CEO
- Eric Bernard
- Employees
- 18.34K
- Beta
- 1.20
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($106.78 ÷ $171.20) − 1 = -37.63% (DCF, example).